Has Kenneth Gustke, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,222,758 in general payments to Kenneth Gustke, MD across 222 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kenneth Gustke, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kenneth Gustke, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kenneth Gustke, MD

Orthopaedic Surgery · Temple Terrace, FLNPI 1144225855

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $4,954,191 of the $5,222,758 with a category attached, or 94.9%. Stryker accounts for 99.4% of it on its own, with 15 other manufacturers making up the rest. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,222,758in general payments, 2019–2025

Across 222 payments — averaging $23,526 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$5.2M
Orthosensor Inc.$26K
Zimmer Biomet$1K
Total Joint Orthopedics, Inc.$312
Innovation Technologies Inc$269
Solventum Corporation$255
plus $926 from 10 others

$30,821in research payments, 2019–2025

Across 18 payments — averaging $1712.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Zimmer Biomet$31K

What the payments were for

Royalty or licence$4,954,19195%
Consulting fees$253,9755%
Travel & lodging$10,1980%
Food & beverage$4,3950%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	181	$5,193,521
Orthosensor Inc.	6	$26,332
Zimmer Biomet	14	$1,143
Total Joint Orthopedics, Inc.	3	$312
Innovation Technologies Inc	2	$269
Solventum Corporation	4	$255
Next Science LLC	2	$234
Sanara Medtech Inc.	1	$181
Biocomposites Inc	2	$174
Linkbio Corp	1	$137
Illuminoss Medical, Inc.	1	$102
Baxter Healthcare	1	$25
Pacira Pharmaceuticals Incorporated	1	$24
Smith+Nephew	1	$21
Pacira Therapeutics, Inc.	1	$18
Fidia Pharma USA Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$5,157,698
TRIATHLON$46,974
Verasense$30,082
NEW PRODUCT DEVELOPMENT$1,085
PERFORMANCE SOLUTIONS$563
Irrisept$269
ROSA$263
SurgX$234
Xperience$234
BlastX$234
CellerateRx$181
TRITANIUM$166
Persona$149
mymobility Platform$128
Stimulan$115
G7$107
Photodynamic Bone Stabilization Procedure Pack$102

How this compares

$5,222,758 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$138,680

Medicare patients

355

Services billed

7,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin	69	$95
Meloxicam	27	$70
Clindamycin Hcl	11	$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Temple Terrace

Mark FrankleTemple Terrace$31M
Roy SandersTemple Terrace$19.6M
Thomas BernasekTemple Terrace$6.4M
Mark MighellTemple Terrace$4.3M
Michael GarciaTemple Terrace$1.1M
Christopher BakerTemple Terrace$575K
John SmallTemple Terrace$467K
Brian PalumboTemple Terrace$414K
Andrew CooperClearwater$102M
Richard HynesMelbourne$34.8M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →